NovaBridge Biosciences (NBP) Other Non-Current Liabilities (2018 - 2026)

NovaBridge Biosciences (NBP) has reported Other Non-Current Liabilities for 6 consecutive years, with $511000.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $511000.0; the TTM figure through Dec 2025 stood at $511000.0 (changed N/A YoY), while the FY2025 annual figure was $511000.0, changed N/A from the prior year.
• Other Non-Current Liabilities fell to $511000.0 in Q4 2025 per NBP's latest filing, from $9.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $2.3 billion in Q4 2021 and bottomed at $511000.0 in Q4 2025.
• Historically, Other Non-Current Liabilities has averaged $336.9 million across 4 years, with a median of $2.4 million in 2022.
• Annual changes were most pronounced in 2021 — Other Non-Current Liabilities jumped 172378.56% — and 2022, when it tumbled 99.9%.
• NovaBridge Biosciences' Other Non-Current Liabilities stood at $2.3 billion in 2021, then slumped by 99.9% to $2.4 million in 2022, then surged by 305.67% to $9.7 million in 2023, then tumbled by 94.72% to $511000.0 in 2025.
• Business Quant data shows NBP's Other Non-Current Liabilities at $511000.0 in Q4 2025, $9.7 million in Q4 2023, and $6.8 million in Q2 2023.